Skip to content

Oruka Therapeutics, Inc.: filings

Every Oruka Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-10fiscal Q2 202632850001213900-26-087231
10-Q2026-05-13fiscal Q1 202632640001213900-26-055769
10-K2026-03-12fiscal FY 202534680001213900-26-026929
10-Q2025-11-12fiscal Q3 202533880001213900-25-109182
10-Q2025-08-11fiscal Q2 202537970001213900-25-074281
10-Q2025-05-14fiscal Q1 202536680001213900-25-043279
10-K2025-03-06fiscal FY 202437430001213900-25-021165
10-Q2024-11-13fiscal Q3 202433550001213900-24-097443
10-Q2024-08-01fiscal Q2 202432910000950170-24-089246
10-Q2024-04-25fiscal Q1 202432710000950170-24-048329
10-K2024-02-01fiscal FY 202335700000950170-24-009809
10-Q2023-10-18fiscal Q3 202332910000950170-23-053972
10-Q2023-07-21fiscal Q1 202332890000950170-23-033834
10-Q2023-04-24fiscal Q1 202332690000950170-23-014091
10-K2023-02-24fiscal FY 202236700000950170-23-004379
10-Q2022-10-28fiscal Q3 202234950001564590-22-035668
10-Q2022-08-02fiscal Q2 202234930001564590-22-027468
10-Q2022-05-02fiscal Q1 202230650001564590-22-017043
10-K2022-03-14fiscal FY 202135670001564590-22-010075
10-Q2021-11-02fiscal Q3 202134890001564590-21-053546
10-Q2021-08-04fiscal Q2 202134880001564590-21-040795
10-Q2021-05-11fiscal Q1 202131660001564590-21-026534
10-K2021-03-18fiscal FY 202035690001564590-21-014148
10-Q2020-11-02fiscal Q3 202033910001564590-20-049656
10-Q2020-08-05fiscal Q2 202032890001564590-20-036784
10-Q2020-05-06fiscal Q1 202031650001564590-20-021946
10-K2020-02-18fiscal FY 201934670001564590-20-005032
10-Q2019-11-06fiscal Q3 201933940001564590-19-041051
10-Q2019-08-01fiscal Q2 201932860001564590-19-027966
10-Q2019-05-08fiscal Q1 201931650001564590-19-017210
10-K2019-02-27fiscal FY 201833660001564590-19-004882
10-Q2018-11-14fiscal Q3 201832910001564590-18-029560
10-Q2018-08-09fiscal Q2 201830760001564590-18-021065
10-Q2018-05-08fiscal Q1 201826530001564590-18-011830
10-K2018-03-22fiscal FY 201729570001564590-18-006566
10-Q2017-11-09fiscal Q3 201726660001564590-17-023278
10-Q2017-08-03fiscal Q2 201726660001564590-17-015389
10-Q2017-05-15fiscal Q1 201726520001564590-17-010898
10-K2017-03-21fiscal FY 201628540001564590-17-004897
10-Q2016-11-14fiscal Q3 201626650001564590-16-029259
10-Q2016-08-09fiscal Q2 201626650001564590-16-023718
10-Q2016-05-11fiscal Q1 201624490001564590-16-019116
10-K2016-03-17fiscal FY 201525510001564590-16-014989
10-Q2015-11-12fiscal Q3 201524630001564590-15-010627
10-Q2015-08-11fiscal Q2 201523590001564590-15-007020
10-Q2015-05-12fiscal Q1 201523470001564590-15-004080
10-K2015-03-19fiscal FY 201426530001564590-15-001840
10-Q2014-11-12fiscal Q3 201426720001564590-14-005554
10-Q2014-08-13fiscal Q2 201425680001564590-14-003628
10-Q2014-05-13fiscal Q1 201427850001564590-14-002121
10-K2014-03-20fiscal FY 201330900001564590-14-000934
10-Q2013-11-13fiscal Q3 2013311090001564590-13-001316
10-Q2013-08-13fiscal Q2 2013311080001564590-13-000333
10-Q2013-05-13fiscal Q1 201330900001564590-13-000015
10-K2013-03-21fiscal FY 201230870001193125-13-119763
10-Q2012-11-13fiscal Q3 2012301050001193125-12-467759
10-Q2012-08-13fiscal Q2 2012331200001193125-12-352660
10-Q2012-05-14fiscal Q1 201227800001193125-12-231528
10-K2012-03-27fiscal FY 201126790001193125-12-134451
10-Q2011-11-14fiscal Q3 201126930001193125-11-311150
10-Q2011-08-15fiscal Q2 2011301140001193125-11-223373

Inspect the source

Entity
Oruka Therapeutics, Inc. / CIK 0000907654
Captured
2026-09-20T05:05:43.293Z
SEC response SHA-256
3e23b48bd43d48690cc2da8767bd994ea7ae37e724c61a9cefa6f2950dc21518

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000907654.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))